Human Genome Epidemiology Literature Finder
Rare Diseases
|
Records 1 - 30 (of 1881 Records) |
| Query Trace: Acute Myeloid Leukemia[original query] |
|---|
| A novel lncRNA SNHG29 regulates EP300- related histone acetylation modification and inhibits FLT3-ITD AML development. Leukemia 2023 5 . Shan Liu, Jie Zhou, Xiangling Ye, Danni Chen, Weimin Chen, Yaobin Lin, Zhizhong Chen, Biyun Chen, Jin Sha |
| Characteristic immunophenotype and gene co-mutational status orchestrate to optimize the prognosis of CEBPA mutant acute myeloid leukemia. Blood cancer journal 2023 5 13 (1): 70. Xinjie Chen, Diyaer Abuduaini, Yuliang Zhang, Jun Long, Xiaojing Lin, Hongming Zhu, Jianfeng Li, Yang Sh |
| Survival improvement of patients with FLT3 mutated acute myeloid leukemia: results from a prospective 9 years cohort. Blood cancer journal 2023 5 13 (1): 69. Guadalupe Oñate, Marta Pratcorona, Ana Garrido, Alicia Artigas-Baleri, Alex Bataller, Mar Tormo, Montserrat Arnan, Susana Vives, Rosa Coll, Olga Salamero, Ferran Vall-Llovera, Antònia Sampol, Antoni Garcia, Marta Cervera, Sara Garcia Avila, Joan Bargay, Xavier Ortín, Josep F Nomdedéu, Jordi Esteve, Jorge Sierra, |
| Interaction between myelodysplasia-related gene mutations and ontogeny in acute myeloid leukemia. Blood advances 2023 5 . Joseph G W McCarter, David Nemirovsky, Christopher A Famulare, Noushin Farnoud, Abhinita S Mohanty, Zoe S Stone-Molloy, Jordan Chervin, Brian J Ball, Zachary D Epstein-Peterson, Maria E Arcila, Aaron J Stonestrom, Andrew Dunbar, Sheng F Cai, Jacob L Glass, Mark B Geyer, Raajit K Rampal, Ellin Berman, Omar I Abdel-Wahab, Eytan M Stein, Martin S Tallman, Ross L Levine, Aaron D Goldberg, Elli Papaemmanuil, Yanming Zhang, Mikhail Roshal, Andriy Derkach, Wenbin Xi |
| Clinical characteristics and prognosis analysis of patients with de novo ASXL1-mutated AML treated with the C-HUNAN-AML-15 protocol: A multicenter study by the South China Pediatric AML Collaborative Group. Cancer medicine 2023 5 . Minhui Zeng, Keke Chen, Xin Tian, Runying Zou, Xiaoqin Feng, Chunfu Li, Jian Li, Mincui Zheng, Huirong Mai, Lihua Yang, Yingyi He, Honggui Xu, Hong Wen, Xiangling |
| Prevalence and clinical expression of germline predisposition to myeloid neoplasms in adults with marrow hypocellularity. Blood 2023 5 . Elisabetta Molteni, Elisa Bono, Anna Galli, Chiara Elena, Jacqueline Ferrari, Nicolas Fiorelli, Sara Pozzi, Virginia Valeria Ferretti, Martina Sarchi, Ettore Rizzo, Virginia Camilotto, Emanuela Boveri, Mario Cazzola, Luca Malcova |
| Phe354Leu polymorphism of the liver kinase B1 gene as a prognostic factor in adult egyptian patients with acute myeloid leukemia. Heliyon 2023 5 9 (5): e15415. Ola A Hussein, Hany A Labib, Rasha Haggag, Maha Mahmoud Hamed Sa |
| LSC17 score complements genetics and measurable residual disease in acute myeloid leukemia: an ALFA study. Blood advances 2023 5 . Loic Vasseur, Laurène Fenwarth, Jérôme Lambert, Stéphane de Botton, Martin Figeac, Céline Villenet, Maël Heiblig, Pierre-Yves Dumas, Christian Récher, Celine Berthon, Emilie Lemasle, Delphine Lebon, Juliette Lambert, Christine Terré, Karine Celli-Lebras, Hervé Dombret, Claude Preudhomme, Meyling H Cheok, Raphaël A Itzykson, Nicolas Duploy |
| Association of social deprivation with survival in younger adult patients with AML: an Alliance study. Blood advances 2023 5 . Melanie Rebechi, Jessica Kohlschmidt, Krzysztof Mrózek, Deedra Nicolet, Alice S Mims, James S Blachly, Shelley Orwick, Karilyn Larkin, Christopher C Oakes, Andrew Hantel, Andrew J Carroll, William Blum, Bayard L Powell, Geoffrey L Uy, Richard M Stone, Richard A Larson, John C Byrd, Electra D Paskett, Jesse J Plascak, Ann-Kathrin Eisfe |
| Obesity in adult acute myeloid leukemia is not associated with inferior response or survival even when dose capping anthracyclines: An ECOG-ACRIN analysis. Cancer 2023 5 . James M Foran, Zhuoxin Sun, Catherine Lai, Hugo F Fernandez, Larry D Cripe, Rhett P Ketterling, Janis Racevskis, Selina M Luger, Elisabeth Paietta, Hillard M Lazarus, Yanming Zhang, John M Bennett, Ross L Levine, Jacob M Rowe, Mark R Litzow, Martin S Tallm |
| Comparison of the 2022 and 2017 European LeukemiaNet risk classifications in a real-life cohort of the PETHEMA group. Blood cancer journal 2023 5 13 (1): 77. Claudia Sargas, Rosa Ayala, María J Larráyoz, María C Chillón, Eduardo Rodriguez-Arboli, Cristina Bilbao, Esther Prados de la Torre, David Martínez-Cuadrón, Rebeca Rodríguez-Veiga, Blanca Boluda, Cristina Gil, Teresa Bernal, Juan Bergua, Lorenzo Algarra, Mar Tormo, Pilar Martínez-Sánchez, Elena Soria, Josefina Serrano, Juan M Alonso-Dominguez, Raimundo García, María Luz Amigo, Pilar Herrera-Puente, María J Sayas, Esperanza Lavilla-Rubira, Joaquín Martínez-López, María J Calasanz, Ramón García-Sanz, José A Pérez-Simón, María T Gómez Casares, Joaquín Sánchez-García, Eva Barragán, Pau Montesinos, |
| Somatic exonic deletions in RUNX1 constitutes a novel recurrent genomic abnormality in acute myeloid leukemia. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 4 . Eriksson Anna, Engvall Marie, Mathot Lucy, Österroos Albin, Rippin Martin, Cavelier Lucia, Ladenvall Claes, Baliakas Panagiot |
| Co-mutation of ASXL1 and SF3B1 Predicts Poorer Overall Survival Than Isolated ASXL1 or SF3B1 Mutations. In vivo (Athens, Greece) 2023 4 37 (3): 985-993. Jinming Song, Lynn Moscinski, Ethan Yang, Haipeng Shao, Mohammad Hussaini, Hailing Zha |
| TP53 and RB1 alterations characterize poor prognostic subgroups in pediatric acute myeloid leukemia. Genes, chromosomes & cancer 2023 4 . Yusuke Hara, Norio Shiba, Kenichi Yoshida, Genki Yamato, Taeko Kaburagi, Yuichi Shiraishi, Kentaro Ohki, Yusuke Shiozawa, Machiko Kawamura, Hirohide Kawasaki, Manabu Sotomatsu, Takumi Takizawa, Hidemasa Matsuo, Akira Shimada, Nobutaka Kiyokawa, Daisuke Tomizawa, Takashi Taga, Etsuro Ito, Keizo Horibe, Satoru Miyano, Souichi Adachi, Tomohiko Taki, Seishi Ogawa, Yasuhide Hayas |
| Identification of Adult Patients With Classical Dyskeratosis Congenita or Cryptic Telomere Biology Disorder by Telomere Length Screening Using Age-modified Criteria. HemaSphere 2023 4 7 (5): e874. Mareike Tometten, Martin Kirschner, Robert Meyer, Matthias Begemann, Insa Halfmeyer, Margherita Vieri, Kim Kricheldorf, Angela Maurer, Uwe Platzbecker, Markus Radsak, Philippe Schafhausen, Selim Corbacioglu, Britta Höchsmann, C Matthias Wilk, Claas Hinze, Jörg Chromik, Michael Heuser, Michael Kreuter, Steffen Koschmieder, Jens Panse, Susanne Isfort, Ingo Kurth, Tim H Brümmendorf, Fabian Bei |
| NGS-defined measurable residual disease (MRD) after initial chemotherapy as a prognostic biomarker for acute myeloid leukemia. Blood cancer journal 2023 4 13 (1): 59. Yonghong Li, Jose Solis-Ruiz, Fei Yang, Nicola Long, Carmen H Tong, Felicitas L Lacbawan, Frederick K Racke, Richard D Pre |
| NEXT-GENERATION SEQUENCING-BASED GENOMIC PROFILING OF CHILDREN WITH ACUTE MYELOID LEUKEMIA. The Journal of molecular diagnostics : JMD 2023 4 . Szilvia Krizsán, Borbála Péterffy, Bálint Egyed, Tibor Nagy, Endre Sebestyén, Lajos László Hegyi, Zsuzsanna Jakab, Dániel J Erdélyi, Judit Müller, György Péter, Krisztina Csanádi, Krisztián Kállay, Gergely Kriván, Gábor Barna, Gábor Bedics, Irén Haltrich, Gábor Ottóffy, Katalin Csernus, Ágnes Vojcek, Lilla Györgyi Tiszlavicz, Krisztina Mita Gábor, Ágnes Kelemen, Péter Hauser, Zsuzsanna Gaál, István Szegedi, Anikó Ujfalusi, Béla Kajtár, Csongor Kiss, András Matolcsy, Botond Tímár, Gábor Kovács, Donát Alpár, Csaba Böd |
| UBTF tandem duplications define a distinct subtype of adult de novo acute myeloid leukemia. Leukemia 2023 4 . Nicolas Duployez, Loïc Vasseur, Rathana Kim, Laëtitia Largeaud, Marie Passet, Anaïs L'Haridon, Pierre Lemaire, Laurène Fenwarth, Sandrine Geffroy, Nathalie Helevaut, Karine Celli-Lebras, Lionel Adès, Delphine Lebon, Céline Berthon, Alice Marceau-Renaut, Meyling Cheok, Juliette Lambert, Christian Récher, Emmanuel Raffoux, Jean-Baptiste Micol, Arnaud Pigneux, Claude Gardin, Eric Delabesse, Jean Soulier, Mathilde Hunault, Hervé Dombret, Raphael Itzykson, Emmanuelle Clappier, Claude Preudhom |
| FDA Analysis of Ineligibility for Acute Myeloid Leukemia Clinical Trials by Race and Ethnicity. Clinical lymphoma, myeloma & leukemia 2023 4 . Dianne Pulte, Laura Fernandes, Guo Wei, Ashley Woods, Kelly J Norsworthy, Nicole Gormley, Bindu Kanapuru, Thomas E Gwise, Richard Pazdur, Julie Schneider, Marc R Theoret, Lola A Fashoyin-Aje, R Angelo de Cla |
| Validation and refinement of the 2022 European LeukemiaNet genetic risk stratification of acute myeloid leukemia. Leukemia 2023 4 . Rausch Christian, Rothenberg-Thurley Maja, Dufour Annika, Schneider Stephanie, Gittinger Hanna, Sauerland Cristina, Görlich Dennis, Krug Utz, Berdel Wolfgang E, Woermann Bernhard J, Hiddemann Wolfgang, Braess Jan, von Bergwelt-Baildon Michael, Spiekermann Karsten, Herold Tobias, Metzeler Klaus |
| DNA Sequencing to Detect Residual Disease in Adults With Acute Myeloid Leukemia Prior to Hematopoietic Cell Transplant. JAMA 2023 3 329 (9): 745-755. Dillon Laura W, Gui Gege, Page Kristin M, Ravindra Niveditha, Wong Zoë C, Andrew Georgia, Mukherjee Devdeep, Zeger Scott L, El Chaer Firas, Spellman Stephen, Howard Alan, Chen Karen, Auletta Jeffery, Devine Steven M, Jimenez Jimenez Antonio Martin, De Lima Marcos J G, Litzow Mark R, Kebriaei Partow, Saber Wael, Weisdorf Daniel J, Hourigan Christopher |
| FLT3-TKD in the prognosis of patients with acute myeloid leukemia: A meta-analysis. Frontiers in oncology 2023 3 13 1086846. Li Shuping, Li Na, Chen Yun, Zheng Zhihua, Guo Y |
| The clinical impact of IKZF1 mutation in acute myeloid leukemia. Experimental hematology & oncology 2023 3 12 (1): 33. Zhang Xiang, Huang Aijie, Liu Lixia, Qin Jiayue, Wang Chengcheng, Yang Min, Lou Yinjun, Wang Lei, Ni Xiong, Hu Xiaoxia, Tang Gusheng, Zhang Mengmeng, Cao Shanbo, Mao Liping, Qian Jiejin, Xu Weilai, Wei Juying, Xu Gaixiang, Meng Haitao, Mai Wenyuan, Yang Chunmei, Zhu Honghu, Tong Hongyan, Yang Jianmin, Yu Wenjuan, Wang Jianmin, Jin J |
| HLA Class I genotype is associated with relapse risk after allogeneic stem cell transplantation for NPM1-mutated AML. Transplantation and cellular therapy 2023 3 . Narayan Rupa, Niroula Abhishek, Wang Tao, Kuxhausen Michelle, He Meilun, Meyer Everett, Chen Yi-Bin, Bhatt Vijaya Raj, Beitinjaneh Amer, Nishihori Taiga, Sharma Akshay, Brown Valerie I, Kamoun Malek, Diaz Miguel A, Abid Muhammad Bilal, Askar Medhat, Kanakry Christopher G, Gragert Loren, Bolon Yung-Tsi, Marsh Steven G E, Gadalla Shahinaz M, Paczesny Sophie, Spellman Stephen, Lee Stephanie |
| Clinical characteristics and prognostic significance of DNA methylation regulatory gene mutations in acute myeloid leukemia. Clinical epigenetics 2023 3 15 (1): 54. Xu Xiaoyan, Wang Hong, Han Haohao, Yao Yifang, Li Xueqian, Qi Jiaqian, Cai Chengsen, Zhou Meng, Tang Yaqiong, Pan Tingting, Zhang Ziyan, Yang Jingyi, Wu Depei, Han Y |
| [Analysis of epigenetic modification gene mutations among patients with acute myeloid leukemia]. Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2023 3 40 (4): 435-441. Wei Jifeng, Qiu Huiying, Zhou Hang, Chen Zhe, Miao Lei, Wang Ying, Zhao Lidong, Cai Zhim |
| RUNX1 together with DAT mutations predicted poor outcome in acute myeloid leukemia. Leukemia & lymphoma 2023 3 1-11. Xiao Jinyan, Xie Jundan, Zhou Biqi, Liu Yujie, Lu Jing, Jiang Airui, Yao Hong, Qiu Qiaocheng, Ding Zixuan, Xue Shengli, Tang Xiaowen, Qiu Huiying, Chen Suning, Shen Hongjie, Wu Depei, Xu Ya |
| Myeloid sarcoma with NPM1 mutation may be clinically and genetically distinct from AML with NPM1 mutation: a study from the Bone Marrow Pathology Group. Leukemia & lymphoma 2023 3 1-9. Ramia de Cap Maximiliano, Wu Leo P, Hirt Christian, Pihan German A, Patel Sanjay S, Tam Wayne, Bueso-Ramos Carlos E, Kanagal-Shamanna Rashmi, Raess Philipp W, Siddon Alexa, Narayanan Damodaran, Morgan Elizabeth A, Pinkus Geraldine S, Mason Emily F, Hsi Eric D, Rogers Heesun J, Toth Laura, Foucar Kathryn, Hurwitz Stephanie N, Bagg Adam, Rets Anton, George Tracy I, Orazi Attilio, Arber Daniel A, Hasserjian Robert P, Weinberg Olga K, |
| Combined flow cytometry natural killer immunophenotyping and KIR/HLA-C genotyping reveal remarkable differences in acute myeloid leukemia patients, but suggest an overall impairment of the natural killer response. Frontiers in medicine 2023 3 10 1148748. Cianga Vlad Andrei, Rusu Cristina, Pavel-Tanasa Mariana, Dascalescu Angela, Danaila Catalin, Harnau Sebastian, Aanei Carmen-Mariana, Cianga Pet |
| The Clinical Picture of the ERCC6L2 Disease - from Bone Marrow Failure to Acute Leukemia. Blood 2023 3 . Hakkarainen Marja, Kaaja Ilse, Douglas Suvi P M, Vulliamy Thomas J, Dokal Inderjeet, Soulier Jean, Larcher Lise, Peffault de Latour Régis, Leblanc Thierry M, Sicre de Fontbrune Flore, Siitonen Timo, Lohi Olli, Hellström-Lindberg Eva, Barbany Gisela, Tesi Bianca, Shimamura Akiko, Beier Fabian, Jackson Sharon Rosalie, Kuperman Amir, Falik Zaccai Tzipora C, Tamary Hannah, Mecucci Cristina, Capolsini Ilaria, Jahnukainen Kirsi, Salmenniemi Urpu, Niinimäki Riitta, Varilo Teppo, Kilpivaara Outi, Wartiovaara-Kautto Ul |
- Page last reviewed:Feb 1, 2023
- Page last updated:Jun 02, 2023
- Content source: